Weight loss · Kansas City area, MO
Weight loss and obesity studies in Kansas City area, MO
9 recruiting studies have a site in the Kansas City area. This page includes nearby cities such as Independence, Lee's Summit, North Kansas City, Liberty.
9 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
2 studies with pay posted
Exact amounts posted by the research company for each study. The button opens that study’s own page.
Pays up to
$10,500
Clinical Research Study of an Investigational Medication in Overweight but Otherwise Healthy Participants
ICON · Lenexa, KS
Participation in this study includes 1 screening visit, 1 stay of 6 nights and 6 outpatient visits.
Ages 18–55 · Male/Female · Non Smoker
View study & apply (opens in a new tab)Opens ICON’s page for this exact study
Pays up to
$7,750
Clinical Research Study of an Investigational Medication in Overweight but Otherwise Healthy Volunteers
ICON · Lenexa, KS
Participation in this study includes 1 screening visit, 1 stay of 13 nights and 1 follow-up visit.
Ages 18–55 · Male/Female · Non Smoker
View study & apply (opens in a new tab)Opens ICON’s page for this exact study
More recruiting studies (pay not posted)
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Hoffmann-La Roche
- Location
- Kansas City, MO + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
AstraZeneca
- Location
- Kansas City, MO + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- City of Saint Peters, MO + 136 other US sites
- Eligibility basics
- Ages 45–99
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Amgen
- Location
- Kansas City, MO + 30 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Amgen
- Location
- Kansas City, MO + 69 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 1/Phase 2
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
35Pharma Inc
- Location
- Kansas City, MO + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Amgen
- Location
- Kansas City, MO + 117 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
MBX Biosciences
- Location
- Kansas City, MO + 3 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 2
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
University of Missouri, Kansas City
- Location
- Kansas City, MO
- Eligibility basics
- Ages 18+
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.